ArticleFrontiers in molecular biosciences2026
The impact of zeaxanthin and lycopene on fatty acid beta-oxidation in isolated peroxisomes from frozen livers of obese rats.
Article in Frontiers in molecular biosciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Over the past decade, research has emphasized the role of organelle dysfunction in various diseases, particularly obesity and related metabolic disorders. Peroxisomes, essential for lipid metabolism and redox balance, have been associated with obesity-related complications. Although carotenoids such as zeaxanthin (Zi) and lycopene (Ly) are known for their antioxidant and anti-inflammatory properties, their effects on peroxisomal function in obesity remain unexamined. This study evaluated the effects of Zi and Ly supplementation on peroxisomal β-oxidation, oxidative stress, and inflammatory markers in rats fed a high-fat diet (HFD). Forty male Wistar rats were divided into four groups: normal diet, HFD, Zi (100 mg/kg), and Ly (25 mg/kg). After a 12-week HFD regimen, the rats received Zi and Ly for an additional 5 weeks. Peroxisome function was assessed by measuring the activity of marker enzymes such as catalase and acyl-CoA oxidase, along with evaluations of antioxidant enzyme activity, oxidative stress indicators, inflammatory biomarkers, and lipid profiles. Serum fatty acid content was analyzed using gas chromatography/mass spectrometry (GC/MS). Results showed that HFD intake resulted in significant weight gain and peroxisomal dysfunction, indicated by reduced enzyme activities and increased serum saturated fatty acids. In contrast, Zi and Ly treatments improved peroxisomal β-oxidation, altered fatty acid profiles, decreased oxidative stress and inflammation markers, and enhanced antioxidant enzyme activities. These findings suggest that Zi and Ly can restore peroxisomal function impaired by high-fat diets, highlighting peroxisomal homeostasis as a potential therapeutic target in obesity. Further research is recommended to elucidate the underlying molecular mechanisms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.